EUVIMEDEUVIMED entdecken
Fallbericht

Successful Lipid Lowering With Alirocumab and Bempedoic Acid in a Statin-Intolerant Heterozygous Familial Hypercholesterolemia With Markedly Elevated Lipoprotein(a): A Case Report

Madhura S Nootigattu, Preet Mukesh Shah

Cureus · 18.11.2026

DOI: 10.7759/cureus.119906 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 18.11.2026. Verfasst von Madhura S Nootigattu und 1 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intensive lipid lowering is essential in the management of heterozygous familial hypercholesterolaemia (HeFH). Statin intolerance necessitates consideration of alternative lipid-lowering therapies, while concomitantly elevated lipoprotein(a) (Lp(a)) further increases cardiovascular risk and the importance of adequate lipid reduction. We report the case of a 66-year-old woman with severe statin intolerance and dyslipidaemia. Following assessment in the lipid clinic, she was identified to have genetically confirmed HeFH with severely elevated Lp(a) at 617 nmol/L. Her computerized tomography coronary angiogram (CTCA) demonstrated unobstructed coronary arteries with no lesions seen, and her coronary artery calcium (CAC) score was 0. Despite a baseline low-density lipoprotein cholesterol (LDL-C) of 8.4 mmol/L and non-high-density lipoprotein cholesterol (non-HDL-C) of 9.1 mmol/L in July 2025, her lipid parameters improved substantially with alirocumab and bempedoic acid. LDL-C improved by 69.0% to 2.6 mmol/L, and non-HDL-C decreased by 64.8% from baseline to a level of 3.2 mmol/L. As non-HDL-C remained above the target of

Zitieren

APA

Nootigattu, M. S., & Shah, P. M. (2026). Successful Lipid Lowering With Alirocumab and Bempedoic Acid in a Statin-Intolerant Heterozygous Familial Hypercholesterolemia With Markedly Elevated Lipoprotein(a): A Case Report. Cureus. https://doi.org/10.7759/cureus.119906

Vancouver

Nootigattu MS, Shah PM. Successful Lipid Lowering With Alirocumab and Bempedoic Acid in a Statin-Intolerant Heterozygous Familial Hypercholesterolemia With Markedly Elevated Lipoprotein(a): A Case Report. Cureus. 2026. doi:10.7759/cureus.119906

BibTeX
@article{Nootigattu2026,
  author = {Nootigattu, Madhura S and Shah, Preet Mukesh},
  title = {Successful Lipid Lowering With Alirocumab and Bempedoic Acid in a Statin-Intolerant Heterozygous Familial Hypercholesterolemia With Markedly Elevated Lipoprotein(a): A Case Report},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.119906}
}
Kostenlos starten →